West China Second University Hospital
Clinical trials sponsored by West China Second University Hospital, explained in plain language.
-
New hope for kids with rare immune disorder: targeted drug added to standard chemotherapy
Disease control Recruiting nowThis study is testing if adding a new targeted drug called luvometinib to standard chemotherapy works better for children with a serious form of Langerhans cell histiocytosis (LCH), a rare immune system disorder. The trial will enroll 120 children across multiple hospitals and ra…
Phase: NA • Sponsor: West China Second University Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New pill offers hope for kids with rare bone disease, could replace harsh chemo
Disease control Recruiting nowThis study is testing a daily pill called luvometinib for children with a rare bone disease called Langerhans Cell Histiocytosis (LCH). The goal is to see if this targeted pill can control the disease better and with fewer side effects than the standard chemotherapy treatment. Re…
Phase: NA • Sponsor: West China Second University Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC